IGMS - IGM prices $200.0M stock offering

IGM Biosciences (NASDAQ:IGMS) has priced its underwritten public offering of ~8.7M shares of its non-voting common stock at a price to the public of $23.00/share for expected total gross proceeds of ~$200.0M. Underwriters over-allotment is an additional 1,304,347 shares of its voting common stock at the public offering price. All of the shares in the offering will be sold by IGM. Offering is expected to close on or about April 1, 2022. Earlier, IGM Biosciences announces proposed stock offering. Share are up 2.6% after hours following Q4 earnings result.

For further details see:

IGM prices $200.0M stock offering